Search research articles
Contact Us
Filters
Showing results (81-90 of 108) with videos related to
Page
of 11
Sort By:
Lancet (London, England)
|
December 18, 1993
Individual risk assessment for intracranial haemorrhage during thrombolytic therapy
M L Simoons, A P Maggioni, G Knatterud, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
October 16, 2012
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial
O Vaccaro, M Masulli, E Bonora, et al.
Heart Disease (Hagerstown, Md.)
|
December 1, 2001
Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial
R Latini, E Santoro, S Masson, et al.
European Heart Journal
|
November 1, 1996
The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico
G L Nicolosi, R Latini, P Marino, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
March 1, 2005
Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting
Aleardo Maresta, M Balducelli, R Latini, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 31, 2023
Characteristics and outcomes in patients with a prior myocardial infarction treated with extended dual antiplatelet therapy with ticagrelor 60 mg: findings from ALETHEIA, a multi-country observational study
M P Bonaca, E Lesén, E Giannitsis, et al.
The American Journal of Cardiology
|
November 1, 1996
Diltiazem improves left ventricular systolic function following acute myocardial infarction treated with streptokinase. The Calcium Antagonist in Reperfusion Study (CARES) Group
J C Nicolau, J A Ramires, A P Maggioni, et al.
Diabetologia
|
May 29, 2012
Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes
C Andersson, L van Gaal, I D Caterson, et al.
Diabetes, Obesity & Metabolism
|
August 2, 2008
Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT)
A M Sharma, I D Caterson, W Coutinho, et al.
International Journal of Cardiology
|
February 7, 2018
Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation
G A Dan, E Badila, E Weiss, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 108) with videos related to
Sort By:
Page
of 11
Lancet (London, England)
|
December 18, 1993
Individual risk assessment for intracranial haemorrhage during thrombolytic therapy
M L Simoons, A P Maggioni, G Knatterud, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
October 16, 2012
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial
O Vaccaro, M Masulli, E Bonora, et al.
Heart Disease (Hagerstown, Md.)
|
December 1, 2001
Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial
R Latini, E Santoro, S Masson, et al.
European Heart Journal
|
November 1, 1996
The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico
G L Nicolosi, R Latini, P Marino, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
March 1, 2005
Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting
Aleardo Maresta, M Balducelli, R Latini, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 31, 2023
Characteristics and outcomes in patients with a prior myocardial infarction treated with extended dual antiplatelet therapy with ticagrelor 60 mg: findings from ALETHEIA, a multi-country observational study
M P Bonaca, E Lesén, E Giannitsis, et al.
The American Journal of Cardiology
|
November 1, 1996
Diltiazem improves left ventricular systolic function following acute myocardial infarction treated with streptokinase. The Calcium Antagonist in Reperfusion Study (CARES) Group
J C Nicolau, J A Ramires, A P Maggioni, et al.
Diabetologia
|
May 29, 2012
Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes
C Andersson, L van Gaal, I D Caterson, et al.
Diabetes, Obesity & Metabolism
|
August 2, 2008
Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT)
A M Sharma, I D Caterson, W Coutinho, et al.
International Journal of Cardiology
|
February 7, 2018
Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation
G A Dan, E Badila, E Weiss, et al.
Page
of 11